:CiECHA ECHA DECLARATION OF INTERESTS1. There is a conflict of interest where the impartiality and objectivity of a decision, opinion

Similar documents
ECHA DECLARATION OF INTERESTS1

CIECHA ECHA DECLARATION OF INTERESTS1

(ECHA EUROPEAN CHEMICALS AGENCY

ECHA DECLARATION OF INTEREST

iecha ECHA DECLARATION OF INTEREST

CECHA EUROPEANCHEMICALSAGENCY Annex 3

ECHA DECLARATION OF INTEREST

5ECHA EUROPEAN CHEMICALS AGENCy

ICECHA EUROPEANCHEMCAL5AGENCY Annex 2

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

fecha EUROPEAN CHEMICALSAGENCY

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

ECHA DECLARATION OF INTEREST

Annex 1 Declaration of Interests Form

ACER. Annex 1 - Name: Position I Involvement in the Board or Agency 1:

Annex 1 Declaration of Interests Form

@ ECHA. Annex 2. that might jeopardise your independence when working with the Agency should

Annex 1 Declaration of Interests Form

ACER. N a. of Interests form. Declaration. Annex hereby declare the following interests that could be prejudicial to my. Name: Romana Jordan

DECLARATION OF PERSONAL INTERESTS 2018

Policy, Procedure and Strategies. Conflict of Interest Policy

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements

Akron General Health System Financial Conflict of Interest Reference Sheet

Versus Arthritis Management of interests policy

Methodological Note to HCP/HCO Disclosure Requirements in the LEO Group including specifications from LEO Pharma A/S Romania Repressentative Office

IPCC CONFLICT OF INTEREST POLICY

National Infrastructure Commission: conflicts of interest policy

ALL LEO TRADEMARKS MENTIONED BELONG TO THE LEO GROUP

Background. Convention on the Prior Informed Consent Procedure for Certain Hazardous Chemicals and Pesticides in International Trade.

LEO Pharma Global Methodological Note to EFPIA HCP/HCO Disclosure Requirements

Institutional Conflicts of Interest in Research Responsible Office: Research & Innovation

Academic Consultancy Service

Intermediation of Interests in the European Union. Questionnaire for EU-level organisations

CONFLICT OF INTEREST MANAGEMENT POLICY

APOLLO HOSPITALS ENTERPRISE LIMITED CODE OF CONDUCT FOR BOARD MEMBERS THE COMPANY

Policy on conflicts of interest in connection with the appointment of appointed members to the FCA Board

Decision on Secondment of National Experts

research must complete, even if they have used the coi.asco.org system)

Moffitt Cancer Center

DECISIONS TAKEN WITH RESPECT TO THE REVIEW OF IPCC PROCESSES AND PROCEDURES CONFLICT OF INTEREST POLICY

Having regard to European Commission decision No C(2008)6866/3,

American Thoracic Society International Conference SUMMARY AND DEFINITIONS OF ATS POLICIES ON CONFLICT OF INTEREST AND TOBACCO INDUSTRY RELATIONSHIPS

ESMO Declaration of Interests (DOI) Statement

Financial Regulation of the European Maritime Safety Agency. Adopted by the Administrative Board on 18 December 2013

Financial Disclosure Form for Investigators in PHS Research

XAVIER UNIVERSITY. Financial Conflict of Interest Policy-Non-Federal Grant Proposals

Journal of Clinical Oncology Author Submission preparation worksheet. Author Disclosure Declaration

1035. Pursuant to Article 95 item 3 of the Constitution of Montenegro, I hereby pass ORDINANCE PROMULGATING THE LAW ON METROLOGY

Research Financial Conflict of Interest Policy. I. Policy Statement

June 2008 CONSORTIUM AGREEMENT SILICON/SILICA FUME/FESI ALLOYS

Policy on Conflicts of Interest of the Medicines Patent Pool Foundation

Instructions for completing a QILDRO Order

2 (22) 3. Appeal. Yours sincerely, Christel Schilliger-Musset 1. Director of Registration. ECHA s internal decision-approval process.

JAMISONPRO APPLICATION INTELLECTUAL PROPERTY LAWYERS PROFESSIONAL LIABILITY INSURANCE NOTICE: THIS IS AN APPLICATION FOR A CLAIMS MADE POLICY

AIFP CODE ON DISCLOSURE OF TRANSFERS OF VALUE FROM PHARMACEUTICAL COMPANIES TO HEALTHCARE PROFESSIONALS AND HEALTHCARE ORGANISATIONS

ARPIM HCP/HCO DISCLOSURE CODE

TEXTS ADOPTED Provisional edition. P8_TA-PROV(2017)0165 Discharge 2015: European Chemicals Agency (ECHA)

REGISTER OF MEMBERS FINANCIAL AND OTHER INTERESTS

Title: Previous Version(s): 8/01, 1/02, 6/06, 1/12, 4/12

GUIDE FOR THE REIMBURSEMENT OF TRAVEL AND ACCOMMODATION EXPENSES AND PAYMENT OF SUBSISTENCE ALLOWANCES

TITLE: Conflict of Interest, Research

GUIDE FOR THE REIMBURSEMENT OF TRAVEL AND ACCOMMODATION EXPENSES AND PAYMENT OF SUBSISTENCE ALLOWANCES

Standard Operating Procedures for Disclosure and Management of Financial Conflicts of Interest

The University of the Virgin Islands Conflict of Interest and Disclosure Policy

The following definitions will be used to inform the policy implementation:

BENDIGO AND ADELAIDE BANK GROUP FIT AND PROPER POLICY

Conflict of Interest Policy Packet

Nominating Committee Charter

Central Office of Research Administration

THE POLAND-RUSSIA CROSS-BORDER COOPERATION PROGRAMME ST CALL FOR PROPOSALS BUDGET

REGENERON PHARMACEUTICALS, INC. FINANCIAL CONFLICTS OF INTEREST POLICY FOR PHS-FUNDED RESEARCH

DISCLOSURES OF TRANSFERS OF VALUE: SUMMARY OF METHODOLOGY

PROJECT COOPERATION AGREEMENT (PCA)

Effective for assurance engagements beginning on or after 1 September 2011.

INFORMATION ON THE PROCESSING OF PERSONAL DATA

GREENVILLE HEALTH SYSTEM POLICY AND PROCEDURES Manual of Policy Directives POLICY NAME: Greenville Health System

Privacy Policy and Personal Data

5Y EUR DUO (200% PARTICIPATION) NOTE ON EURO STOXX 50

APPLICATION FORM for the designation CHARTERED ARBITRATOR (C.Arb)

CUSTOMER INFORMATION SHEET - LEGAL ENTITY

GROUP PRIVACY POLICY. Adopted June 20th, 2017 by each of the Boards of Carnegie Holding AB and Carnegie Investment Bank AB (publ).

APPLICATION FOR DIRECTORSHIP POSITION OF BANK

Tool: Template for registration of private interests

Effective Date: February 3, 2016

Non-Find 2: Addendum to BU Non-PHS Financial Interest Disclosure Form

NOTE REGARDING THE SAMPLE DOCUMENTS: This sample document is provided for informational purposes only and does not constitute legal advice or counsel.

NORTH CAROLINA AGRICULTURAL AND TECHNICAL STATE UNIVERSITY

2 nd INDEPENDENT EXTERNAL EVALUATION of the EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS (FRA)

Division of Research Policy

Adoption: 8 December 2017 FOURTH EVALUATION ROUND. Corruption prevention in respect of members of parliament, judges and prosecutors

Financial Conflict of Interest (FCOI) Training for Investigators

Effects of using International Financial Reporting Standards (IFRS) in the EU: public consultation

BAHAMAS INTERNATIONAL SECURITIES EXCHANGE LIMITED BISX RULES

Evidence of compliance

This final response is in addition to our first stage response submitted to CESR on 10 September and covers the following sections:

Member Circular March Implementation of the EU General Data Protection Regulation 2016/679 General Guidance to Members

Transcription:

or recommendation of the Agency and/or its bodies, is or might in the public perception be compromised by an interest held by, or entrusted to, an individual working for the Agency. Position in ECHA: Management Board Member Last name: Grabner First Name: Alojz ECHA Procedure for Prevention and Management of potential Conflicts of Interest. interest. In particular, high quality of (scientific) expertise is by nature based on prior jeopardise your independence when working with the Agency should thus also be On the other hand it should be emphasised that this declaration of interest form does not experience. Declaring an interest does therefore not automatically disqualify you or limit There is a conflict of interest where the impartiality and objectivity of a decision, opinion Please note that having an interest does not necessarily mean having a conflict of your participation in the activities of the European Chemicals Agency. contain an exhaustive list of potential interests and that all other elements that might indicated. Your answers will then be reviewed and dealt with in accordance with the ECHA DECLARATION OF INTERESTS1 EU ROPEAN CH EM ICALS AG ENCY :CiECHA 1 amended 2014 align on 20 March to the template for the ECHA Declaration of Interest with the format used the revised policy for managing potential conflicts in of interests (MB/07/2014 final). hereby declares to have the following interests:

I. Employment, consultancy, legal representation or advice Within the past 5 years, were you employed or have you had any other professional relationship with a commercial entity2 or other organisation3 with an interest in the regulatory field of activity of ECHA? D Yes, and more in particular: IL Membership of Governing Body, Scientific Advisory Body or equivalent structure Within the past 5 years, have you participated in the internal decision-making of a commercial entity or other organisation with an interest in the regulatory field of activity of ECHA (e.g. board membership, directorship) or have you participated in the works of a Scientific Advisory Body with voting rights on the outputs of that entity? E Yes, and more in particular: 2 This includes any commercial business, consultancy, research institution or other enterprise whose funding is significantly derived from commercial sources. It also includes independent own commercial businesses, law offices, consultancies or similar. An organisation includes governmental, international or non-profit organisations, as well as interest groups.

(from..until organisation non-monetary support? any support from a commercial entity or other organisation with an interest in the regulatory field of activity of ECHA, including grants, rents, sponsorships, fellowships, IV. Research funding Yes, and more in particular: above that can be perceived as creating a potential conflict of interest? Within the past 5 years, have you had any membership or affiliation other than the Yes, and more in particular: Within the past 5 years, have you or the research entity to which you belong received IlL Other membership or affiliation

V.. Investments Do you have current in vestments in a commercial entity with an interest in the regulatory field of activity of ECHA, including holding of stocks and shares, stock options, equity, bonds, partnership interest in the capital of such undertaking, one of its subsidiaries or a company in the capital of which it has a holding and which amounts to more than 10,000 EUR per commercial entity or entitling you to a voting right of 5% or more in such commercial entity?4 LI Yes, and mote in particular: Investment Name of entity organisation or commercial VI. Intellectual Property Do you have any intellectual property rights (e.g. patent, trademark, copyright or proprietary know-how) in the regulatory field of activity of ECHA that might create a potential conflict of interest? LI Yes, and more in particular: Intellectual Property Name of organisation commercial entity or Description You may exclude financial interests held through an investment fund, pension fund and/or interests in non nominal unit trusts or similar arrangements, provided that these investments are broadly diversified and you have no influence on their financial management.

when working for the Agency? Are there any other elements that could be seen as jeopardising your independence VIII. Other relevant information field of activity of ECHA? Yes, and more in particular: regulatory field of activity of ECHA for a commercial entity or other organisation as part Within the past 5 years, have you provided any expert opinion or testimony in the VII. Public statements and positions paid or unpaid, where you represented interests or defended an opinion in the regulatory of a regulatory, legislative or judicial process? Have you held an office or other position,

IX. Interests held by close family members5 Does any of your close family members hold any current interests in the regulatory field of activity of the Agency (as specified above in the sections 1.-VIlI.)? Function/Activity Name of Description organisation or commercial entity I wish to have any reference to interests held by close family members removed if this declaration is to be made public on the ECHA webste.6 I hereby declare that I have read both the ECHA Procedure on Prevention and Management of potential Conflicts of Interest and the related ECHA Guidance document and that the above Declaration of Interest is at my best knowledge complete. I understand that for all members of the ECHA bodies, the Executive Director and the other ECHA management staff (Directors and Heads of Unit), as well as for the chairpersons of the ECHA Committees this declaration will be published on the ECHA website. Please note that the European Chemicals Agency will ensure on its part that your personal data hereby submitted is processed as required by Reoulat/on (EC) No 45/2001 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data. You have the right to access and rectify that data. To exercise these rights, please contact the relevant secretariat. Digitalno podpisa I, Date: 13. 6. 2017 Signature:ou=government,cn serialnumber=e Datum: 201 707.10 16:36:35 +0200 (If you need more sheets to declare your interests, do not hesitate to use blank ones, but please sign each one of them and attach them to this form.) For this purpose close family members are considered to be the persons forming a household with the person making this declaration (spouse, partner, and/or dependent children). For privacy reasons neither the relationship nor the name is to be included. Only current interests held by close family members are of relevance and not past interests. 6 As full transparency is one of the general principles of this Procedure, this option should only be used in case the consent of the individual concerned has not been obtained, when he/she has objected to the disclosure on compelling legitimate grounds or if there is reason to believe that the legitimate interests of the individual involved might be prejudiced by the disclosure (see also Regulation fec) No 45/2001 on the protection of personal data).